ProtocolNow Announces Daniel F. O’Keeffe, M.D. as Chairman of the Board

NASHVILLE, Tenn., Sept. 17, 2020 /PRNewswire/ — ProtocolNow, leading provider of real-time protocols accessible anytime, anywhere, has appointed Daniel O’Keeffe as Chairman of the board. Dr. O’Keeffe, an obstetrician-gynecologist with over 20 years experience, will leverage his relationships and experience in the field to lead the strategic growth and adoption of ProtocolNow as the standard for managing protocols.

The announcement follows the recent appointments of Charles Lukens as CEO and PJ Likhmania as CIO, to solidify the leadership team.

“As an early adopter of technology to assist in operating his medical practice, O’Keeffe’s experience will offer critical direction as the business scales,” said CIO PJ Likhmania. He added that “leveraging O’Keeffe’s direct connections to the front line of providing medical service brings agility to our product research and development.”

O’Keeffe has practiced medicine and led teams of physicians in both California and Arizona. He completed his residency at University of California Irvine, and is now a partner in his practice in Scottsdale, AZ. As a specialist in maternal-fetal medicine, O’Keeffe shared his excitement for ProtocolNow to change the mantra in the medical industry around protocols from “static checklists to living and changing plans that, coupled with our technology, deliver measurable improvement to standardizing care and improving patient outcomes.”

About ProtocolNow
ProtocolNow is a software platform that houses the protocol lifecycle. In business, protocols are everywhere, and properly managed and followed protocols deliver more consistent service and results. ProtocolNow empowers clients to develop, train on, apply and refine protocols with their easy-to-use proprietary platform. Learn more at ProtocolNow.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/protocolnow-announces-daniel-f-okeeffe-md-as-chairman-of-the-board-301133125.html

SOURCE ProtocolNow.com

Staff

Recent Posts

Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results

Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…

51 mins ago

GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health

GE HealthCare to exclusively distribute nCommand Lite by IONIC Health for multi-vendor, multi-modality remote operations…

2 hours ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for…

2 hours ago

Politan Nominates Two Independent Candidates for Masimo Board

Supports Strategic Review of Consumer Business, But Has Serious Concerns Given Masimo’s Broken Governance and…

2 hours ago

Akanda Corp. Announces Pricing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…

2 hours ago